AmpliPhi Biosciences Nets $9.1M From IPO
socalTECH
MAY 11, 2017
San Diego-based AmpliPhy Biosciences , a developer of therapies for treating drug-resistant bacterial infections using bacteriophage technology, said it raised $9.1M The company trades as APHB on the NYSE Small Cap Market. for the company in its IPO.
Let's personalize your content